12194 Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices 

and Supporting Regulations; Form 

Number: CMS–372(S); and OMB Control 

Number: 0938–0272. Through the 

publication of this document we are 

withdrawing that notice (FR document: 

2021–03916) in its entirety. While the 

notice published in error, it will be 

resubmitted for publication and public 

comment when ready. 

Dated: February 25, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–04296 Filed 3–1–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Secretary’s Advisory 

Committee on Human Research 

Protections 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health. 

ACTION: Notice. 

SUMMARY: Pursuant to Section 10(a) of 

the Federal Advisory Committee Act, 

U.S.C. Appendix 2, notice is hereby 

given that the Secretary’s Advisory 

Committee on Human Research 

Protections (SACHRP) will hold a 

meeting that will be open to the public. 

Information about SACHRP, the full 

meeting agenda, and instructions for 

linking to public access will be posted 

on the SACHRP website at http://

www.dhhs.gov/ohrp/sachrp-committee/ 

meetings/index.html. 

DATES: The meeting will be held on 

Tuesday, March 23rd, 2021, from 11:00 

a.m. until 4:30 p.m., and Wednesday, 

March 24, 2021, from 11:00 a.m. until 

4:30 p.m. (times are tentative and 

subject to change). The confirmed times 

and agenda will be posted on the 

SACHRP website when this information 

becomes available. 

ADDRESSES: This meeting will be held 

via webcast. Members of the public may 

also attend the meeting via webcast. 

Instructions for attending via webcast 

will be posted one week prior to the 

meeting at https://www.hhs.gov/ohrp/ 

sachrp-committee/meetings/index.html. 

FOR FURTHER INFORMATION CONTACT: Julia 

Gorey, J.D., Executive Director, 

SACHRP; U.S. Department of Health 

and Human Services, 1101 Wootton 

Parkway, Suite 200, Rockville, 

Maryland 20852; telephone: 240–453– 

8141; fax: 240–453–6909; email address: 

SACHRP@hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

authority of 42 U.S.C. 217a, Section 222 

of the Public Health Service Act, as 

amended, SACHRP was established to 

provide expert advice and 

recommendations to the Secretary of 

Health and Human Services, through 

the Assistant Secretary for Health, on 

issues and topics pertaining to or 

associated with the protection of human 

research subjects. 

The Subpart A Subcommittee (SAS) 

was established by SACHRP in October 

2006 and is charged with developing 

recommendations for consideration by 

SACHRP regarding the application of 

subpart A of 45 CFR part 46 in the 

current research environment. 

The Subcommittee on Harmonization 

(SOH) was established by SACHRP at its 

July 2009 meeting and charged with 

identifying and prioritizing areas in 

which regulations or guidelines for 

human subjects research adopted by 

various agencies or offices within HHS 

would benefit from harmonization, 

consistency, clarity, simplification or 

coordination. 

The SACHRP meeting will open to the 

public at 11:00 a.m., on Tuesday, March 

23, 2021, followed by opening remarks 

from Dr. Jerry Menikoff, Director of 

OHRP and Dr. Douglas Diekema, 

SACHRP Chair. The meeting will begin 

with presentation of recommendations 

on Justice as an Ethical Concept in 45 

CFR 46, followed by an expert panel 

discussion of draft recommendations on 

Mandatory Exploratory Biopsies in 

Research. The day will conclude with 

discussion of a new SACHRP topic, IRB 

Authority to Restrict Use of Data in 

Research. March 24th will include 

presentation of Interactions between 

Sponsors, Clinical Trial Sites, and 

Research Subjects, and lastly, 

Consideration of Risks to Bystanders in 

Research. Other topics may be added; 

for the full and updated meeting agenda, 

see http://www.dhhs.gov/ohrp/sachrpcommittee/meetings/index.html. 

The public will have an opportunity 

to send comments to SACHRP during 

the meeting’s public comment session 

or to submit written public comments in 

advance. Persons who wish to provide 

public comments should review 

instructions at https://www.hhs.gov/ 

ohrp/sachrp-committee/meetings/ 

index.html and respond by midnight 

Wednesday, March 18th, 2021, ET. 

Individuals submitting written 

statements as public comment should 

submit their comments to SACHRP at 

SACHRP@hhs.gov. Comments are 

limited to three minutes each. 

Time will be allotted for public 

comment on both days. Note that public 

comment must be relevant to topics 

currently being addressed by SACHRP. 

Dated: February 22, 2021. 

Julia G. Gorey, 

Executive Director, SACHRP, Office for 

Human Research Protections. 

[FR Doc. 2021–04244 Filed 3–1–21; 8:45 am] 

BILLING CODE 4150–36–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; NIDA– 

L Conflict SEP. 

Date: March 25, 2021 

Time: 11:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Preethy Nayar, Ph.D. 

Scientific Review Officer Scientific Review 

Branch National Institute on Drug Abuse, 

NIH 301 North Stonestreet Avenue Bethesda, 

MD 20892, 301–443–4577, nayarp2@

csr.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Implementing the HIV Service Cascade for 

Justice-Involved Populations (U01—Clinical 

Trial Optional). 

Date: March 30, 2021. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Sheila Pirooznia, Ph.D.; 

Scientific Review Officer, Division of 

Extramural Review, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue Bethesda, 

MD 20892, (301) 496–9350 sheila.pirooznia@

nih.gov. 


jbell on DSKJLSW7X2PROD with NOTICES